Teva Pharmaceutical reported 1.99B in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Aspen Pharmacare APN:SJ 10.53B 1.08B
Cipla CIPLA:IN 21.37B 678.5M
Dr.Reddys Laboratories DRRD:IN 20.28B 3.26B
Guangzhou Baiy 600332:CH 14.11B 1.05B
Jiangsu Hengrui Me. 600276:CH CH 974.35M 130.53M
Kalbe Farma Tbk Pt KLBF:IJ 3846.35B 241.5B
Richter Gedeon RICHT:HB 71.8B 4.12B
Sh Fosun Pharma 600196:CH CH 5.27B 984.54M
Sun Pharmaceuticals SUNP:IN IR 25218.6M 1275.7M
Teva Pharmaceutical TEVA:IT 1.99B 2M